Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy

This clinical trial compares the effectiveness of anticoagulation vs antiplatelet therapy for secondary stroke prevention in patients with cryptogenic stroke and evidence of atrial cardiopathy.